These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3015630)

  • 1. HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy.
    De Rossi A; Gassa OD; del Mistro A; Faulkner Valle G; Bianchi LC
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):411-8. PubMed ID: 3015630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
    Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC
    Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological survey of HIV infection in the Veneto region of Italy.
    Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O
    Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG antibodies to HTLV-III associated antigens in patients with AIDS and at risk for AIDS in The Netherlands.
    Goudsmit J; Tersmette T; Kabel P; Miedema F; Melief C
    AIDS Res; 1983-1984; 1(4):231-6. PubMed ID: 6100824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of antibodies to human T-lymphotropic retrovirus type III in lymphoadenopathy syndrome patients and in individuals at risk for acquired immune deficiency syndrome (AIDS) in Italy.
    Sirianni MC; Rossi P; Moroni M; Romagnani S; Lazzarin A; Carbonari M; Scarpati B; Mariani M; Manconi PE; Del Giacco GS
    Am J Epidemiol; 1986 Feb; 123(2):308-15. PubMed ID: 3004198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
    Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
    Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
    Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 9. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAV/HTLV-III neutralizing antibodies in the sera of patients with AIDS, lymphadenopathy syndrome and asymptomatic seropositive individuals.
    Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Chieco-Bianchi L
    Tumori; 1986 Jun; 72(3):219-24. PubMed ID: 3016957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
    Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
    Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
    AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84.
    Mortimer PP; Jesson WJ; Vandervelde EM; Pereira MS
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1176-8. PubMed ID: 2985170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
    Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
    Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
    Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
    AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.